Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Bronchus and Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07498933
What this trial is testing

FAP-targeted PET/NIR in Lung Malignant Tumors

Who this might be right for
Non-Small Cell Lung CancerPET/CTNeoadjuvant Therapy
Peking University People's Hospital 200
Not applicableActive Not RecruitingNCT04056247
What this trial is testing

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IV Malignant MelanomaStage IV Small Cell Lung Cancer+2 more
OncoHost Ltd. 10,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07482605
What this trial is testing

Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

Who this might be right for
Lung Cancer (NSCLC)Malignant Pleural Effusions (Mpe)- Pleurodesis
Jiangmen Central Hospital 63
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06690216
What this trial is testing

Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors

Who this might be right for
Glioblastoma (GBM)Head and Neck Squamous Cell CarcinomaNon-Small Cell Lung Cancer+1 more
Man Hu 100
Early research (Phase 1)Study completedNCT00635791
What this trial is testing

Phase I Study of Vorinostat and Sorafenib in Advanced Cancer

Who this might be right for
Malignant Solid TumourRenal Cell CarcinomaNon Small Cell Lung Carcinoma
University of Colorado, Denver 36
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Very early researchStudy completedNCT04678440
What this trial is testing

[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients

Who this might be right for
Lung Cancer, Nonsmall Cell
University of California, Davis 5
Testing effectiveness (Phase 2)Ended earlyNCT03366103
What this trial is testing

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmRecurrent Lung Small Cell CarcinomaRecurrent Malignant Solid Neoplasm+6 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT03236935
What this trial is testing

Phase Ib of L-NMMA and Pembrolizumab

Who this might be right for
Non-Small Cell Lung CancerMalignant MelanomaHead and Neck Squamous Cell Carcinoma+3 more
The Methodist Hospital Research Institute 12
Early research (Phase 1)Study completedNCT01014598
What this trial is testing

Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis

Who this might be right for
Metastatic Malignant Neoplasm in the LungStage IIIB Non-Small Cell Lung CancerStage IV Adult Soft Tissue Sarcoma+1 more
Roswell Park Cancer Institute 11
Testing effectiveness (Phase 2)Looking for participantsNCT06769295
What this trial is testing

A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC

Who this might be right for
Lung Cancer, Non-Small Cell
Sichuan University 28
Testing effectiveness (Phase 2)Ended earlyNCT02459067
What this trial is testing

ImmuniCell® in Patients With Advanced Cancers

Who this might be right for
Malignant MelanomaNon-small Cell Lung CancerRenal Cell Cancer
TC Biopharm 8
Large-scale testing (Phase 3)Study completedNCT00347412
What this trial is testing

Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Cellectar Biosciences, Inc. 903
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT05544929
What this trial is testing

Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Who this might be right for
Carcinoma, Non-Small-Cell LungCutaneous MelanomaCarcinoma, Renal Cell+9 more
Novartis Pharmaceuticals 126
Early research (Phase 1)WithdrawnNCT06982222
What this trial is testing

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+4 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT04969315
What this trial is testing

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

Who this might be right for
Renal Cell CancerCastrate Resistant Prostate CancerNon Small Cell Lung Cancer+1 more
Portage Biotech 35
Testing effectiveness (Phase 2)WithdrawnNCT03004105
What this trial is testing

MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Malignant Neoplasm of Respiratory and Intrathoracic Organ CarcinomaAdvanced Lung CancerRecurrent Nonsmall Cell Lung Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Next Page